Synchron

At Synchron, we are driven by a radical vision: to harness neurotechnology to address the limitations of the human body. Our journey began in 2012, born from the idea of creating a brain-computer interface (BCI) that could be implanted without the need for open brain surgery. This led to the development of our pioneering endovascular BCI, a solution that utilizes a minimally-invasive procedure, akin to placing a stent, to implant our technology. Our core mission is to restore autonomy and improve the lives of individuals experiencing severe paralysis due to conditions like ALS, stroke, or spinal cord injury. We are a global team of dedicated scientists, innovators, and forward-thinkers, united by the goal of bringing the first commercially scalable BCI to millions who need it most.

Our culture is one of relentless innovation and a deep commitment to ethical development. We believe in pushing the boundaries of what's possible while prioritizing patient safety and well-being. The development of our Stentrode™ technology and, more recently, Chiral AI™, a proprietary foundation model of cognition, underscores our dedication to advancing the field of neurotechnology. We are not just developing a medical device; we are working to create a new interface layer between humans and technology, one that can empower individuals to communicate, create, and connect with the world in ways previously unimaginable. We collaborate with leading institutions and technology partners, like NVIDIA and Apple, to ensure our BCI systems are seamlessly integrated and accessible, always keeping the user experience at the forefront of our design. At Synchron, we are not just building technology; we are building hope and new possibilities for a future where physical limitations no longer define human potential.